PL376744A1 - Pharmaceutical tablets containing tibolone and a coating - Google Patents

Pharmaceutical tablets containing tibolone and a coating

Info

Publication number
PL376744A1
PL376744A1 PL376744A PL37674403A PL376744A1 PL 376744 A1 PL376744 A1 PL 376744A1 PL 376744 A PL376744 A PL 376744A PL 37674403 A PL37674403 A PL 37674403A PL 376744 A1 PL376744 A1 PL 376744A1
Authority
PL
Poland
Prior art keywords
coating
tablets containing
pharmaceutical tablets
tibolone
containing tibolone
Prior art date
Application number
PL376744A
Other languages
Polish (pl)
Inventor
Haan Pieter De
Lare Cornelis Elisabeth Johannus Van
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Publication of PL376744A1 publication Critical patent/PL376744A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL376744A 2002-11-20 2003-11-13 Pharmaceutical tablets containing tibolone and a coating PL376744A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42774002P 2002-11-20 2002-11-20
EP02079920 2002-11-20

Publications (1)

Publication Number Publication Date
PL376744A1 true PL376744A1 (en) 2006-01-09

Family

ID=52340857

Family Applications (1)

Application Number Title Priority Date Filing Date
PL376744A PL376744A1 (en) 2002-11-20 2003-11-13 Pharmaceutical tablets containing tibolone and a coating

Country Status (11)

Country Link
EP (1) EP1565168A1 (en)
JP (1) JP2006508144A (en)
AU (1) AU2003298290A1 (en)
BR (1) BR0316417A (en)
CA (1) CA2505485A1 (en)
MX (1) MXPA05005381A (en)
NZ (1) NZ539715A (en)
PL (1) PL376744A1 (en)
RU (1) RU2005119197A (en)
TW (1) TW200418525A (en)
WO (1) WO2004045587A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE344020T1 (en) * 2004-02-06 2006-11-15 Helm Ag PHARMACEUTICAL PREPARATIONS CONTAINING AMORPHIC TIBOLONE
WO2005084682A1 (en) * 2004-03-08 2005-09-15 Pharmaceutical Services Inc. (Psi Nv.) Pharmaceutical composition comprising cyclodextrin complex of tibolone
CZ300465B6 (en) * 2007-07-25 2009-05-27 Zentiva, A. S. Process for preparing compressed pharmaceutical formulation containing tibolone
WO2017191266A1 (en) 2016-05-04 2017-11-09 Mithra Pharmaceuticals S.A. Use of sugar-alcohols in tibolone compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL123984A (en) * 1997-04-22 2004-09-27 Akzo Nobel Nv Pharmaceutical dosage units comprising tibolone and a pharmaceutically acceptable carrier
DE69702985T2 (en) * 1997-09-23 2001-02-15 Akzo Nobel N.V., Arnheim/Arnhem Dosage forms containing steroid with a steroid-tight envelope
SK284569B6 (en) * 1998-10-16 2005-06-02 Akzo Nobel N.V. High purity compound of (7alpha,17alpha)-17-hydroxy-7-methyl-19- nor-17-pregn-5(10)-en-20-yn-3-one, method for its preparation and pharmaceutical dosage unit comprising thereof
JP2002068965A (en) * 2000-08-31 2002-03-08 Teikoku Hormone Mfg Co Ltd Single-layer sugar-coated tablet and method for producing the same

Also Published As

Publication number Publication date
CA2505485A1 (en) 2004-06-03
NZ539715A (en) 2006-04-28
EP1565168A1 (en) 2005-08-24
BR0316417A (en) 2005-10-11
TW200418525A (en) 2004-10-01
WO2004045587A1 (en) 2004-06-03
AU2003298290A1 (en) 2004-06-15
RU2005119197A (en) 2006-02-10
JP2006508144A (en) 2006-03-09
MXPA05005381A (en) 2005-08-26

Similar Documents

Publication Publication Date Title
TWI350184B (en) High drug load tablet
HUP0402293A3 (en) Orodispersible tablets containing fexofenadine, coated granules and process for its preparation
GB0229021D0 (en) Pharmaceutical pellets comprising tamsulosin and a process for making the same
IL166079A0 (en) Sustained-release tablet comprising reboxetine
IL165746A0 (en) Lasofoxifene tablet and its coating
AU137637S (en) A pharmaceutical tablet
IL146632A0 (en) Pharmaceutical tablets
AU137736S (en) A pharmaceutical tablet
HUP0500004A3 (en) Extended release pharmaceutical tablet of metformin
AU145547S (en) A tablet for example a pharmaceutical tablet
PL367985A1 (en) Swallow tablet comprising paracetamol
PL367262A1 (en) A pharmaceutical tablet having a high api content
GB2409645B (en) Flower essence-containing medicaments
AU145546S (en) A tablet for example a pharmaceutical tablet
HRP20050430A2 (en) Pharmaceutical tablets containing tibolone and a coating
AU155150S (en) Pharmaceutical packaging
AU155083S (en) Pharmaceutical packaging
HK1079124A (en) Pharmaceutical tablets containing tibolone and a coating
GB2383988B (en) Pill dispenser
AU153406S (en) A tablet
IL150614A0 (en) Tablet dispenser
GB0018663D0 (en) Coated tablets
IL147206A0 (en) Tablet dispenser
CA88762S (en) Pharmaceutical tablet
AU148729S (en) Tablet

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)